Woods Investment Company

Woods Investment is a Taiwan-incorporated private special purpose vehicle formed in 2021 to execute the share-swap acquisition and restructuring of Taiwan Liposome Company. Public disclosures describe it as a company limited by shares organized under Taiwan law, created specifically for the transaction rather than as an operating biotech, pharma, or healthcare company. Following the October 8, 2021 share swap, Taiwan Liposome became a wholly owned subsidiary of Woods Investment, with a subsequent restructuring contemplated under TLC BioSciences Corp. Based on the available evidence, Woods Investment itself appears to function primarily as a transaction and holding entity rather than a standalone life sciences operating business.